Germering, Germany

Jutta Muller-Derlich

This inventor holds 2 USPTO granted patents. Top assignees: Plasmaselect Gmbh Teterow, Therasorb Medizinische Systeme Gmbh. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jutta Muller-Derlich. Retrieved from https://idiyas.com/inventor/jutta-muller-derlich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jutta Muller-Derlich: Innovator in Immunological Solutions

Introduction

Jutta Muller-Derlich is a prominent inventor based in Germering, Germany. She has made significant contributions to the field of immunology, particularly in the area of organ transplantation. With a total of 2 patents, her work focuses on preventing immunological rejection of transplanted organs.

Latest Patents

One of her latest patents is titled "Ameliorating immunological rejection of allograft." This invention provides a method to prevent or ameliorate hyperacute or acute rejection of a human donor organ transplanted to a human recipient. Hyperacute rejection typically occurs when a recipient has preformed anti-HLA antibodies against the transplanted organ. Acute rejection happens when the recipient forms antibodies against the organ post-transplant. The method involves passing the recipient's plasma over a sterile and pyrogen-free column coupled to anti-human immunoglobulin antibodies, which effectively removes a significant portion of immunoglobulin from the plasma.

Another notable patent is for "Sterile and pyrogen-free columns containing coupled protein for binding." This method produces a sterile and pyrogen-free column containing coupled protein, which is used to remove predetermined substances from human blood. The process ensures that sterilization is maintained throughout production by using sterile and pyrogen-free raw materials at each step. The resulting product is a pathogen-free, purified solution of protein that binds to substances such as LDL or immunoglobulin.

Career Highlights

Throughout her career, Jutta has worked with various companies, including Plasmaselect GmbH and Therasorb Medizinische Systeme GmbH. Her innovative approaches have significantly impacted the field of medical technology and organ transplantation.

Collaborations

Jutta has collaborated with notable professionals in her field, including Reiner Spaethe and Franz A Bieber. These collaborations have further enhanced her research and development efforts.

Conclusion

Jutta Muller-Derlich is a trailblazer in the field of immunology, with her patents addressing critical challenges in organ transplantation. Her work continues to influence advancements in medical technology and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…